These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 7467147)

  • 1. [Splenectomy in malignant hematological diseases].
    Steruská M; Hrubisko M; Lipsic T; Schnorrer M; Cárský S
    Vnitr Lek; 1980 Oct; 26(10):951-7. PubMed ID: 7467147
    [No Abstract]   [Full Text] [Related]  

  • 2. [Chronic malignant histiocytosis: 5 cases of a special form of lympho-reticular systemic disease].
    Schreml W; Galle J; Heimpel H
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1100-2. PubMed ID: 611801
    [No Abstract]   [Full Text] [Related]  

  • 3. [Splenectomy in the light of current theories].
    Urasiński I
    Pol Tyg Lek; 1982 Oct; 37(37):1109-12. PubMed ID: 6761663
    [No Abstract]   [Full Text] [Related]  

  • 4. [Splenectomy in myeloproliferative diseases].
    Berliner S; Shoenfeld Y; Pinkhas J
    Harefuah; 1980 Mar; 98(6):274-5. PubMed ID: 7409655
    [No Abstract]   [Full Text] [Related]  

  • 5. [Indications for splenectomy in leukemia, lymphoma and bone marrow aplasia--tactics, technic, complications].
    Popovici A; Nicoară S; Grigoriu G; Stoica I; Mitulescu L; Toma M; Ciurea S; Berceanu S
    Rev Chir Oncol Radiol O R L Oftalmol Stomatol Chir; 1986; 35(4):241-52. PubMed ID: 2948222
    [No Abstract]   [Full Text] [Related]  

  • 6. General principles of treatment.
    Schouten HC
    Ann Oncol; 2007 Jan; 18 Suppl 1():i29-i32. PubMed ID: 17311818
    [No Abstract]   [Full Text] [Related]  

  • 7. [Morbidity and mortality in splenectomy for hematologic indication].
    Barbier P; Leupin L; Lichtenhahn P; Teuscher J
    Helv Chir Acta; 1983 Mar; 49(6):791-4. PubMed ID: 6862980
    [No Abstract]   [Full Text] [Related]  

  • 8. [Nonmyeloablative allogeneic stem cell transplantation in elder patients with hematological malignancies].
    Yoshida T
    Rinsho Ketsueki; 2004 Feb; 45(2):132-8. PubMed ID: 15045821
    [No Abstract]   [Full Text] [Related]  

  • 9. Response evaluation and long-term follow-up.
    Schouten HC
    Ann Oncol; 2007 Jan; 18 Suppl 1():i33-i36. PubMed ID: 17311820
    [No Abstract]   [Full Text] [Related]  

  • 10. Splenectomy in leukaemia and the reticuloses.
    Holt JM; Witts LJ
    Q J Med; 1966 Jul; 35(139):369-84. PubMed ID: 5225399
    [No Abstract]   [Full Text] [Related]  

  • 11. [Splenectomy in immune thrombocytopenia and other hematological diseases].
    Lanzi S; Lancini GP; Piardi T; Biasca F; Ottaviani GM; Rossi G; Pizzoccaro C; Pouchè A
    G Chir; 1999; 20(11-12):479-86. PubMed ID: 10645065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Less usual haematological indications for splenectomy (author's transl)].
    Friedmann B; Brabec V
    Cas Lek Cesk; 1981 Oct; 120(41):1235-9. PubMed ID: 7344794
    [No Abstract]   [Full Text] [Related]  

  • 13. The selection of patients for splenectomy.
    Weatherall DJ
    Ann R Coll Surg Engl; 1971 Jan; 48(1):29. PubMed ID: 5572221
    [No Abstract]   [Full Text] [Related]  

  • 14. [Management of chronic myeloproliferative disorders].
    Ikkala E; Hormila P
    Duodecim; 1989; 105(11):1007-15. PubMed ID: 2473873
    [No Abstract]   [Full Text] [Related]  

  • 15. [Splenectomy in the treatment of hematologic diseases].
    Popović M; Petrović M; Milovanović A; Matić S; Petrović M; Bosković D; Basić M
    Acta Chir Iugosl; 1997-1998; 44-45(1-1):37-42. PubMed ID: 10951812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular genetic evidence of Y chromosome loss in male patients with hematological disorders.
    Zhang LJ; Shin ES; Yu ZX; Li SB
    Chin Med J (Engl); 2007 Nov; 120(22):2002-5. PubMed ID: 18067786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Guidelines on the provision of facilities for the care of adult patients with haematological malignancies (including leukaemia and lymphoma and severe bone marrow failure). British Committee for Standards in Haematology Clinical Haematology Task Force.
    Clin Lab Haematol; 1995 Mar; 17(1):3-10. PubMed ID: 7621625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Chemotherapy of malignant hematological diseases].
    SANCHEZ MEDAL L
    Gac Med Mex; 1953; 83(6):443-51. PubMed ID: 13151339
    [No Abstract]   [Full Text] [Related]  

  • 19. Splenectomy in patients with mixed myelodysplastic/myeloproliferative disease.
    Kraemer D; Rüdiger T; Reimer P; Müller-Hermelink HK; Wilhelm M
    Ann Hematol; 2002 Jun; 81(6):308-11. PubMed ID: 12107559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Therapeutic effects of peripheral blood stem cell transplantation following combination chemotherapy using ranimustine, cytarabine, etoposide and cyclophosphamide for patients with hematological malignancies].
    Yamane T; Ohta T; Kou KR; Hashimoto S; Takekawa K; Hirai N; Tanaka K; Hasuike T; Hirai M; Ohta K
    Gan To Kagaku Ryoho; 1994 May; 21(6):903-6. PubMed ID: 7910450
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.